Penciclovir Articles
Mylan confirms first-to-file patent challenge to Cephalon’s sleep-disorder drug Nuvigil
12 January 2010
Barrier to distribute Novartis' Denavir
20 March 2006
Novartis completes SB antiviral buy
4 January 2001
GlaxoSmithKline on December 27?
13 December 2000
Glaxo Wellcome/SmithKline Beecham merger still dogged by FTC demands
16 November 2000
GW/SB merger delayed until end of year
11 September 2000
SB sells Kytril, Famvir and Vectavir for $2.9bn
31 August 2000
Selecting Diseases Suitable For OTC Treatment
4 December 1998
SB's Bid For OTC Denavir Meets With Split Vote
3 December 1998
World Antiviral Market Forecasts To 2005
20 February 1998
UK Industry Code Of Practice Review
2 July 1997
Upbeat UK Companies At Goldman Sachs Conference
17 June 1997
Penciclovir Launched In USA
5 May 1997
Record Number Of New Chemical Entities In 1996
20 January 1997
SmithKline Beecham 3rd Qtr Earnings Leap 20%
28 October 1996
SB's Denavir Cleared For Cold Sores In USA
7 October 1996
First Launch Of SB's Cold Sore Drug Penciclovir
10 June 1996
SmithKline Beecham Unveils Power Pipeline
9 October 1995
FDA C'tee Gives Thumbs Down For OTC Zovirax
23 January 1995
ADAPTING TO HEALTH CARE REFORM THE SB WAY
17 May 1993
ACICLOVIR VERSUS PENCICLOVIR
10 May 1993
Showing 1-27 of 27 articles
- 1
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
